Explainable Causal Reinforcement Learning: Optimizing Precision Oncology Under Real-Time Constraints

Explainable Causal Reinforcement Learning for precision oncology clinical workflows under real-time policy constraints

Researcher Rikin Patel developed a hybrid Causal RL system to bridge the gap between statistical association and clinical causation in oncology. The model utilizes Judea Pearl’s ladder of causation to prevent adverse effects that traditional RL models fail to predict through mere correlation.

Why This Matters

Clinical oncology operates under severe real-time constraints where treatment windows are measured in days and patient conditions fluctuate rapidly. Standard reinforcement learning lacks the capability to distinguish between causation and association, which is a critical failure point in high-stakes precision medicine where toxic accumulation can be fatal. By integrating Structural Causal Models (SCMs), engineers can formalize ‘best practices’ into causal relationships, ensuring that model exploration remains within ethical and pharmacokinetically safe boundaries. This technical shift from predictive accuracy to causal understanding allows for the simulation of counterfactual scenarios—answering what would have happened if a different dosage had been administered.

Key Insights

• Judea Pearl’s Ladder of Causation serves as the conceptual framework for medical AI, moving from simple association to intervention and counterfactual reasoning.
• Structural Causal Models (SCMs) enable the formalization of physiological relationships, such as the 95% confidence link between liver function and chemotherapy dose tolerance.
• Constrained Markov Decision Processes (CMDPs) are required for oncology RL to ensure agents operate within hard toxicity thresholds and clinical guidelines.
• Explainable AI in medicine must transition from feature importance scores to causal reasoning patterns that mirror clinical logic, such as pharmacokinetic simulations.
• The Backdoor Criterion is implemented in causal graphs to adjust for confounders when estimating the effect of treatments on progression-free survival.

Working Examples

Implementation of a structural causal graph for oncology decision-making.

class OncologyCausalGraph:
    def __init__(self, patient_data: pd.DataFrame):
        self.graph = nx.DiGraph()
        self.patient_data = patient_data
        self._build_base_structure()

    def _build_base_structure(self):
        self.graph.add_node("chemotherapy_dose", node_type="treatment", constraints={"min": 0, "max": 100})
        self.graph.add_edge("chemotherapy_dose", "toxicity", effect_type="positive", confidence=0.90)
        self.graph.add_edge("liver_function", "chemotherapy_dose", effect_type="moderator", confidence=0.95)

A constrained RL agent that filters actions based on predicted toxicity violations.

class ConstrainedOncologyAgent(nn.Module):
    def get_action(self, state: torch.Tensor, current_constraints: torch.Tensor) -> torch.Tensor:
        mean, std = self.forward(state)
        normal_dist = torch.distributions.Normal(mean, std)
        candidate_actions = normal_dist.sample((100,))
        with torch.no_grad():
            constraint_violations = []
            for action in candidate_actions:
                state_action = torch.cat([state, action.unsqueeze(0)], dim=-1)
                violations = self.constraint_net(state_action)
                constraint_violations.append(violations)
            # Find actions that satisfy all constraints
            constraint_satisfied = (torch.stack(constraint_violations) <= current_constraints).all(dim=-1)

Practical Applications

• Dosage Optimization: Using SCMs to adjust chemotherapy based on liver function tests; Pitfall: Treating correlation as causation without adjusting for confounders leads to toxic accumulation.
• Dynamic Policy Constraints: Implementing CMDPs to handle treatment windows; Pitfall: Using static constraints that fail to adapt to rapidly changing patient physiological states.
• Causal Explanation Generation: Mapping RL policy decisions to causal pathways for clinician review; Pitfall: Providing raw feature importance which lacks the ‘why’ required for clinical trust.

References:

• https://dev.to/rikinptl/explainable-causal-reinforcement-learning-for-precision-oncology-clinical-workflows-under-real-time-38ip